4845-50-5 Usage
Description
1,4-Dioxane-2,3-diol, also known as Glycerol, is a simple polyol compound with a hydroxyl group attached to each of its three carbon atoms. It is a colorless, odorless, viscous liquid that is hygroscopic in nature. Glycerol is widely used in various industries due to its versatile properties and ability to act as a solvent, sweetener, and humectant.
Uses
Used in Pharmaceutical Industry:
1,4-Dioxane-2,3-diol is used as a pharmaceutical intermediate for the production of various drugs and medications. Its properties make it suitable for use in the synthesis of antibiotics, antifreeze, and other pharmaceutical compounds.
Used in Organic Synthesis:
1,4-Dioxane-2,3-diol serves as an intermediate in organic synthesis, where it is utilized in the production of various chemicals, including cosmetics, lubricants, and polymers. Its versatility as a solvent and its ability to form esters make it a valuable component in the synthesis of a wide range of organic compounds.
Purification Methods
Recrystallise it from Me2CO. With phenylhydrazine it gives glyoxal phenylhydrazone m 175o (from Me2CO/pet ether). The diacetyl derivative has m 105-106o [Head J Chem Soc 1036 1955, Raudnitz Chem Ind (London) 166 1956]. [Beilstein 1 IV 3627.]
Check Digit Verification of cas no
The CAS Registry Mumber 4845-50-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,8,4 and 5 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4845-50:
(6*4)+(5*8)+(4*4)+(3*5)+(2*5)+(1*0)=105
105 % 10 = 5
So 4845-50-5 is a valid CAS Registry Number.
InChI:InChI=1/C4H8O4/c5-3-4(6)8-2-1-7-3/h3-6H,1-2H2
4845-50-5Relevant articles and documents
DERMATOLOGICAL COMPOSITIONS AND METHODS
-
, (2008/06/13)
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.
Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway
-
, (2008/06/13)
Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.
2,3-Dihydroxy-1,4-dioxane: A Stable Synthetic Equivalent of Anhydrous Glyoxal
Venuti, Michael C.
, p. 61 - 63 (2007/10/02)
-